Tongji Xie

机构：Chinese Academy of Medical Sciences & Peking Union Medical College · ORCID：0000-0002-3276-9645

发表论文 85 篇 · 总被引 554 次 · h-index 13

代表论文

• Single-cell and spatial transcriptomics reveal a high glycolysis B cell and tumor-associated macrophages cluster correlated with poor prognosis and exhausted immune microenvironment in diffuse large B-cell lymphoma (2024 · Biomarker Research · 被引 43)
• The co-location of MARCO+ tumor-associated macrophages and CTSE+ tumor cells determined the poor prognosis in intrahepatic cholangiocarcinoma (2024 · Hepatology · 被引 34)
• Mechanism exploration and model construction for small cell transformation in EGFR-mutant lung adenocarcinomas (2024 · Signal Transduction and Targeted Therapy · 被引 24)
• DKK1+ tumor cells inhibited the infiltration of CCL19+ fibroblasts and plasma cells contributing to worse immunotherapy response in hepatocellular carcinoma (2024 · Cell Death and Disease · 被引 13)
• A cohort-based multi-omics identifies nuclear translocation of eIF5B /PD-L1/CD44 complex as the target to overcome Osimertinib resistance of ARID1A-deficient lung adenocarcinoma (2025 · Experimental Hematology and Oncology · 被引 12)
• The co‐location of CD14+APOE+ cells and MMP7+ tumour cells contributed to worse immunotherapy response in non‐small cell lung cancer (2024 · Clinical and Translational Medicine · 被引 11)